4559 — Zeria Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual cashflow statement for Zeria Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	5,722	7,273	9,508	12,619	11,200
Depreciation
Amortisation
Non-Cash Items	439	169	-1,702	-47.9	491
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,481	-433	-3,178	-7,203	-9,083
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	9,080	13,157	12,184	12,922	9,956
Capital Expenditures	-1,421	-2,658	-3,899	-2,734	-2,896
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,472	83.2	-53.6	1,683	194
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2,893	-2,575	-3,952	-1,051	-2,702
Financing Cash Flow Items	-3.52	-3.93	-1.49	—	-2.72
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-4,841	-7,415	-8,124	-7,757	-5,933
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,910	4,515	2,510	4,864	4,167